CN208065578U - A kind of novel sleep therapeutic equipment electrocardio processing system - Google Patents
A kind of novel sleep therapeutic equipment electrocardio processing system Download PDFInfo
- Publication number
- CN208065578U CN208065578U CN201820063839.3U CN201820063839U CN208065578U CN 208065578 U CN208065578 U CN 208065578U CN 201820063839 U CN201820063839 U CN 201820063839U CN 208065578 U CN208065578 U CN 208065578U
- Authority
- CN
- China
- Prior art keywords
- circuit
- connect
- resistance
- processing system
- therapeutic equipment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn - After Issue
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 24
- 238000012545 processing Methods 0.000 title claims abstract description 22
- 230000007958 sleep Effects 0.000 title claims abstract description 21
- 238000004891 communication Methods 0.000 claims abstract description 35
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- 230000004936 stimulating effect Effects 0.000 claims abstract description 17
- 230000001629 suppression Effects 0.000 claims abstract description 15
- 101710170231 Antimicrobial peptide 2 Proteins 0.000 claims description 18
- 230000005611 electricity Effects 0.000 claims description 8
- 210000001699 lower leg Anatomy 0.000 claims description 3
- 241001062009 Indigofera Species 0.000 claims 1
- 230000000638 stimulation Effects 0.000 abstract description 15
- 238000002560 therapeutic procedure Methods 0.000 abstract description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 6
- 206010022437 insomnia Diseases 0.000 abstract description 6
- 210000004556 brain Anatomy 0.000 description 7
- 230000003321 amplification Effects 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000010321 sleep therapy Methods 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 102000009025 Endorphins Human genes 0.000 description 1
- 108010049140 Endorphins Proteins 0.000 description 1
- 241001539473 Euphoria Species 0.000 description 1
- 206010015535 Euphoric mood Diseases 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 210000003715 limbic system Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 238000013546 non-drug therapy Methods 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 239000002438 stress hormone Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 108010050939 thrombocytin Proteins 0.000 description 1
Landscapes
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
The utility model discloses a kind of novel sleep therapeutic equipment electrocardio processing systems, including electrode, preamplifying circuit, microcurrent stimulating control circuit, baseline feedback suppression circuit, bandwidth-limited circuit, pulse voltage Acquisition Circuit, DAC D/A converter modules, MCU intelligent controllers, ADC analog-to-digital conversion modules and a communication module, wherein electrode is connect with preamplifying circuit and microcurrent stimulating control circuit respectively；The output end of baseline feedback suppression circuit is connect with bandwidth-limited circuit, bandwidth-limited circuit is connect with ADC analog-to-digital conversion modules, ADC analog-to-digital conversion modules are connect with MCU intelligent controllers, MCU intelligent controllers are connect with DAC D/A converter modules and communication module, and DAC D/A converter modules are connect with the input terminal of baseline feedback suppression circuit and microcurrent stimulating control circuit respectively.The novel sleep therapeutic equipment electrocardio processing system of the utility model can be realized in stimulating course removes stimulation voltage while ecg signal acquiring, and more effective data are provided for clinic Insomnia therapy.
Description
Technical field
The utility model is related to therapeutic equipment technical fields, particularly relate to a kind of novel sleeping that can acquire heart rate simultaneously
Dormancy therapeutic equipment electrocardio processing system.
Background technology
Stimulation (CES) waveform technology therapy treatment insomnia, referred to as through cranium microcurrent stimulating therapy.CES is a kind of
The non-drug therapy method of the psychiatrics relevant disease such as anxiety, depression, insomnia and children ADHD can be treated.CES is
It is the therapy of maturation, other than curative effect obtains and generally approves, CES has also obtained whole world most countries Bureau of Drugs Supervision and defends
The license of raw department is eaten including most stringent Bureau of Drugs Supervision of the United States Federal (FDA), Europe CE certifications and China national is required
The certification of product Drug Administration, validity and safety are all very definite.
It is that special waveform is transmitted to skull by temples on the treatment spirit of CES, psychology and feelings are responsible in directly stimulation
The movable brain of thread, hypothalamus, limbic system and reticular structure system.It is with following features：
1) promote its secretion release that can adjust the various neurotransmitters of individual mood and cognition, such as endomorphin
(have the effect of calm and generate floaty euphoria, individual immune system can be strengthened), acetylcholine (improves information to transmit
Speed enhances brain memory ability, improves brain function comprehensively), serotonin (may participate in different physiological roles and pathology in intracerebral
The adjusting of state).
2) abnormal brain wave is influenced and improved, is allowed to revert to normal state from abnormal state of affairs.It significantly increases
Eegαwave (brain relaxation state) power, reduces brain electricity δ waves (the sleepy fatigue state of brain) power.
3) secretion of stress hormone is reduced rapidly.
4) improve physiological signal rapidly, such as heart rate, blood pressure, muscle tone, skin electricity, Pi Wen.To which effectively control is tight
Anxiety-depression is opened, emotional state is adjusted.
It is relevant experimental studies have found that, CES can effectively improve brain thrombocytin, norepinephrine and DOPA aqueous amine
It is flat, the secretory volume for having contrastimulant endorphin is improved, and reduce cortisol levels content.
But CES sleep therapies instrument currently on the market carries out micro-current only according to the various therapeutic schemes of setting
Stimulation carries out course of therapy.It can only carry out the inspection of other manner by clinician after the course for the treatment of to the recruitment evaluation for the treatment of
It surveys, finally carries out the doctor's advice of diagnosis and continual cure.
It is well known that heart rate refers to the number of heartbeat per minute under normal person's rest state, it is also quiet heart rate, generally
60~100 beats/min, individual difference can be generated because of age, gender or other physiologic factors.In general, the age is smaller, and heart rate is got over
Soon, the elderly's heartbeat is slower than young man, and the heart rate of women is faster than male of the same age, these are all normal physiological phenomenons.Quiet shape
Under state, adult normal heart rate is 60~100 beats/min, and ideal heart rate should be 55~70 beats/min, and (heart rate of sportsman is more general
Logical adult is partially slow, generally 50 beats/min or so).It is generated due to during carrying out CES detections, having stimulation voltage,
The stimulation voltage of generation can be with heart rate signal mixing, it is difficult to acquire, then also can not just know electrocardiosignal and its related data.
CES sleep therapies instrument i.e. in the prior art its can not provide more effective data for clinical Insomnia therapy.Therefore,
It is designed there is an urgent need for conceiving a kind of novel sleep therapeutic equipment electrocardio processing system, and by rational control circuit to improve above-mentioned ask
Topic makes it have the possibility realized on hardware.
Utility model content
The utility model is intended to provide a kind of novel sleep therapeutic equipment electrocardio processing system, can in stimulating course,
Stimulation voltage is removed while realizing ecg signal acquiring, more effective data are provided for clinic Insomnia therapy.
In order to solve the above technical problems, the technical solution of the utility model is：
A kind of novel sleep therapeutic equipment electrocardio processing system, including：Electrode, preamplifying circuit, microcurrent stimulating control
Circuit, baseline feedback suppression circuit, bandwidth-limited circuit, pulse voltage Acquisition Circuit, DAC D/A converter modules, MCU are intelligently controlled
Device, ADC analog-to-digital conversion modules and a communication module processed, wherein the electrode respectively with the preamplifying circuit and micro- electricity
Flow boost control circuit connection；The preamplifying circuit is connect with the pulse voltage Acquisition Circuit, and the pulse voltage is adopted
Collector is connect with the ADC analog-to-digital conversion modules；The output end of the baseline feedback suppression circuit and bandpass filtering electricity
Road connects, and the bandwidth-limited circuit is connect with the ADC analog-to-digital conversion modules, the ADC analog-to-digital conversion modules and the MCU
Intelligent controller connects, and the MCU intelligent controllers are connect with the DAC D/A converter modules and the communication module, described
DAC D/A converter modules connect with the input terminal of the baseline feedback suppression circuit and the microcurrent stimulating control circuit respectively
It connects.
Preferably, the baseline feedback suppression circuit includes operational amplifier A MP7C, operational amplifier A MP8A, resistance
R17, resistance R22, capacitance C9, wherein the inverting input of the operational amplifier A MP7C is connect with DAC D/A converter modules,
Its output end after resistance R22 with the in-phase input end of the operational amplifier A MP8A by connecting, the operational amplifier
It is provided with resistance R17 and capacitance C9 between the inverting input and output end of AMP8A.
Preferably, the microcurrent stimulating control circuit includes that two-way switching circuit, triode Q4, resistance R18, operation are put
Big device AMP7D, wherein the two-way switching circuit is connect with the collector of the triode Q4；The emitter of the triode Q4
Its base stage is grounded by being connect with the output end of the operational amplifier A MP7D after resistance R18；The operational amplifier A MP7D
In-phase input end connect with the DAC D/A converter modules.
Preferably, the preamplifying circuit includes switching diode Q2, amplifier AMP2, resistance R5, resistance R8, resistance
R12, capacitance C2 and capacitance C3, wherein the switching diode Q2 after resistance R5 with the crus secunda of the amplifier AMP2 by connecting
It connects；The both ends of resistance R8 are connect with the first foot of the amplifier AMP2 and octal respectively；One end of resistance R12 and the electricity
Pole connects, and the other end is connect with the third foot of the amplifier AMP2；Capacitance C2 and capacitance C3 are arranged in parallel, one end of the two with
The 7th foot of the amplifier AMP2 connects, other end ground connection.
Preferably, the communication module is one or two kinds of in wireless communication module or wire communication module,
Described in wireless communication module include but not limited to bluetooth communication, WIFI communication modules, ZigBee communication module, it is described to have
Line communication module includes but not limited to USB interface, RS232 interface, Ethernet interface.
Preferably, the DAC D/A converter modules are 12-bit digital-to-analog converter.
Preferably, the ADC analog-to-digital conversion modules are 16 analog-digital converters or 24 analog-digital converters.
Preferably, the amplifier AMP2 is AD623A amplifiers.
Preferably, operational amplifier A MP7C, operational amplifier A MP8A are that TL064 low-power consumption JFET inputs operation amplifier
Device.
Preferably, operational amplifier A MP7D is TL064 low-power consumption JFET input operational amplifiers.
Using above-mentioned technical proposal, the utility model includes at least following advantageous effect：
Novel sleep therapeutic equipment electrocardio processing system described in the utility model, can pass through circuit in stimulating course
Innovative design remove stimulation voltage while realize ecg signal acquiring, then can be that clinic Insomnia therapy provide and more have
The data of effect.
Description of the drawings
In order to make the content of the utility model be more likely to be clearly understood, below in conjunction with the accompanying drawings, the utility model is made
Further details of explanation, wherein：
Fig. 1 is the schematic diagram of novel sleep therapeutic equipment electrocardio processing system described in the utility model；
Fig. 2 is the circuit diagram of novel sleep therapeutic equipment electrocardio processing system described in the utility model.
Specific implementation mode
Shown in Fig. 1-2, to meet a kind of novel sleep therapeutic equipment electrocardio processing system of the utility model, including：
Electrode, preamplifying circuit, microcurrent stimulating control circuit, baseline feedback suppression circuit, bandwidth-limited circuit, pulse voltage are adopted
Collector, DAC D/A converter modules, MCU intelligent controllers, ADC analog-to-digital conversion modules and a communication module, wherein the electrode
It is connect respectively with the preamplifying circuit and the microcurrent stimulating control circuit；The preamplifying circuit and the pulse
Voltage collection circuit connects, and the pulse voltage Acquisition Circuit is connect with the ADC analog-to-digital conversion modules；The baseline feedback suppression
The output end of circuit processed is connect with the bandwidth-limited circuit, and the bandwidth-limited circuit connects with the ADC analog-to-digital conversion modules
It connects, the ADC analog-to-digital conversion modules are connect with the MCU intelligent controllers, the MCU intelligent controllers and the DAC digital-to-analogues
Conversion module is connected with the communication module, and the DAC D/A converter modules are defeated with the baseline feedback suppression circuit respectively
Enter end to connect with the microcurrent stimulating control circuit.The communication module is connect with a host computer, the host computer include but
It is not limited to computer, Intelligent flat, smart mobile phone.Due to specific communication mode those skilled in the art it is to be understood that therefore originally
Embodiment does not limit this.
Preferably, the baseline feedback suppression circuit includes operational amplifier A MP7C, operational amplifier A MP8A, resistance
R17, resistance R22, capacitance C9, wherein the inverting input of the operational amplifier A MP7C is connect with DAC D/A converter modules,
Its output end after resistance R22 with the in-phase input end of the operational amplifier A MP8A by connecting, the operational amplifier
It is provided with resistance R17 and capacitance C9 between the inverting input and output end of AMP8A.
Preferably, the microcurrent stimulating control circuit includes that two-way switching circuit, triode Q4, resistance R18, operation are put
Big device AMP7D, wherein the two-way switching circuit (preferably bidirectional switching switch, since it is product in the prior art, therefore
Do not repeat herein) it is connect with the collector of the triode Q4；The emitter of the triode Q4 is grounded its base stage and passes through resistance
It is connect with the output end of the operational amplifier A MP7D after R18；The in-phase input end of the operational amplifier A MP7D with it is described
DAC D/A converter modules connect.
Preferably, the preamplifying circuit includes switching diode Q2, amplifier AMP2, resistance R5, resistance R8, resistance
R12, capacitance C2 and capacitance C3, wherein the switching diode Q2 after resistance R5 with the crus secunda of the amplifier AMP2 by connecting
It connects；The both ends of resistance R8 are connect with the first foot of the amplifier AMP2 and octal respectively；One end of resistance R12 and the electricity
Pole connects, and the other end is connect with the third foot of the amplifier AMP2；Capacitance C2 and capacitance C3 are arranged in parallel, one end of the two with
The 7th foot of the amplifier AMP2 connects, other end ground connection.
Preferably, the communication module is one or two kinds of in wireless communication module or wire communication module,
Described in wireless communication module include but not limited to bluetooth communication, WIFI communication modules, ZigBee communication module, it is described to have
Line communication module includes but not limited to USB interface, RS232 interface, Ethernet interface.
Preferably, the DAC D/A converter modules are 12-bit digital-to-analog converter.
Preferably, the ADC analog-to-digital conversion modules are 16 analog-digital converters or 24 analog-digital converters.
Preferably, the amplifier AMP2 is AD623A amplifiers.
Preferably, operational amplifier A MP7C, operational amplifier A MP8A, operational amplifier A MP7D are TL064 low-power consumption
JFET input operational amplifiers.
The operation principle of the utility model is：During carrying out CES detections, it is carried out at the same time the acquisition of heart rate, is led to
It crosses and collected heart rate is analyzed, such as heart rate value HR, heart rate variability HRV etc..The electrocardio and heart rate of acquisition are carried out simultaneously
It preserves, and host computer (electricity is transferred to by the communication technologys such as wired (USB, RS232, Ethernet) or wireless (bluetooth, wifi)
Brain PC, smart mobile phone, Intelligent flat etc.), carry out the storage of data and subsequent analysis.During treatment, preserve corresponding
Heart rate data, can be supplied directly to clinician carry out assessment and diagnose again.
Specifically, the electrode of the electrode and electrocardiogram acquisition of stimulation is same electrode, before being entered by conducting wire signal
Grade amplifying circuit, preamplifying circuit are powered using 5V, and amplification factor is 2 times.The general stimulated current of sleep therapy instrument is less than
2mA, human body impedance are generally 500 ohm, and stimulation voltage is 1V or so, and after 2 times of amplifications, stimulation voltage is enlarged into 2V, by
In stimulation voltage be bi-directional voltage, so peak-to-valley value be 4V meet the amplitude requirement of signal using 5V rail-to-rail amplifiers.Before
DAC D/A converter module intelligent controllers after amplified electrocardiosignal is converted by ADC analog-to-digital conversion modules are set to be acquired.
Stimulation voltage is the known voltage of MCU intelligent controllers control, and stimulation voltage and the collected voltage of ADC analog conversion circuits are pressed
It carries out obtaining the voltage that needs are fed back after adding up according to the proportionality coefficient of K1 and K2.K1 and K2 is the value obtained by experiment test.
Feedback voltage inputs baseline feedback suppression circuit after becoming analog signal by DAC digital-to-analogue conversion circuits, and counteracting is applied in electro photoluminescence
It is added on the baseline voltage of human body.The voltage for removing baseline is filtered by bandwidth-limited circuit again, and carries out the amplification of signal, is amplified
Multiple is set as 200 times, and electrocardiosignal amplification factor entire in this way is 400 times.Electrocardiosignal is generally 1mV or so, amplification
400mV, circuit reserve the baseline voltage that enough possibility do not remove.Bandwidth-limited circuit is designed as 0.1Hz-100Hz, to ensure
The semaphore request for the 0.5Hz-40Hz that electrocardio requires.Electrocardiosignal is converted by ADC analog-digital converters, is intelligently controlled by MCU
Device processed is acquired.Preferably to improve the resolution ratio of electrocardiosignal signal, 24 ADC analog-digital converters are used.MCU intelligence
The collected data of controller further filter out stimulation by way of being filtered digital baseline.Electrocardio letter after digital filtering
Number, using the detection method of Electrocardiograph QRS Wave, calculate heart rate.
Above-mentioned specific implementation mode is only explained in detail the technical solution of the utility model, and the utility model is not
It is only limited only to above-described embodiment, it will be understood by those skilled in the art that every according to above-mentioned principle and spiritual in this practicality
Improvement, replacement on novel foundation, should all be within the protection scope of the utility model.
Claims (10)
1. a kind of novel sleep therapeutic equipment electrocardio processing system, which is characterized in that including：Electrode, preamplifying circuit, micro-current
Boost control circuit, baseline feedback suppression circuit, bandwidth-limited circuit, pulse voltage Acquisition Circuit, DAC D/A converter modules,
MCU intelligent controllers, ADC analog-to-digital conversion modules and a communication module, wherein the electrode respectively with the preamplifying circuit
It is connected with the microcurrent stimulating control circuit；The preamplifying circuit is connect with the pulse voltage Acquisition Circuit, described
Pulse voltage Acquisition Circuit is connect with the ADC analog-to-digital conversion modules；The output end of the baseline feedback suppression circuit with it is described
Bandwidth-limited circuit connects, and the bandwidth-limited circuit is connect with the ADC analog-to-digital conversion modules, the ADC analog-to-digital conversions mould
Block is connect with the MCU intelligent controllers, the MCU intelligent controllers and the DAC D/A converter modules and the communication mould
Block connect, the DAC D/A converter modules respectively with the input terminal of the baseline feedback suppression circuit and the microcurrent stimulating
Control circuit connects.
2. novel sleep therapeutic equipment electrocardio processing system as described in claim 1, it is characterised in that：The baseline feedback inhibits
Circuit includes operational amplifier A MP7C, operational amplifier A MP8A, resistance R17, resistance R22, capacitance C9, wherein the operation is put
The inverting input of big device AMP7C is connect with DAC D/A converter modules, and output end after resistance R22 with the operation by putting
The in-phase input end connection of big device AMP8A, electricity is provided between the inverting input and output end of the operational amplifier A MP8A
Hinder R17 and capacitance C9.
3. novel sleep therapeutic equipment electrocardio processing system as described in claim 1, it is characterised in that：The microcurrent stimulating control
Circuit processed includes two-way switching circuit, triode Q4, resistance R18, operational amplifier A MP7D, wherein the two-way switching circuit
It is connect with the collector of the triode Q4；The emitter of the triode Q4 be grounded its base stage by after resistance R18 with it is described
The output end of operational amplifier A MP7D connects；The in-phase input end of the operational amplifier A MP7D and the DAC digital-to-analogue conversions
Module connects.
4. novel sleep therapeutic equipment electrocardio processing system as described in claim 1, it is characterised in that：The preamplifying circuit
Including switching diode Q2, amplifier AMP2, resistance R5, resistance R8, resistance R12, capacitance C2 and capacitance C3, wherein the switch
Diode Q2 after resistance R5 with the crus secunda of the amplifier AMP2 by connecting；The both ends of resistance R8 respectively with the amplifier
The first foot and octal of AMP2 connects；One end of resistance R12 is connect with the electrode, and the other end is with the amplifier AMP2's
Third foot connects；Capacitance C2 and capacitance C3 are arranged in parallel, and one end of the two is connect with the 7th foot of the amplifier AMP2, another
End ground connection.
5. novel sleep therapeutic equipment electrocardio processing system as described in claim 1, it is characterised in that：The communication module is nothing
It is one or two kinds of in line communication module or wire communication module, wherein the wireless communication module includes but not limited to indigo plant
Tooth communication module, WIFI communication modules, ZigBee communication module, the wire communication module include but not limited to USB interface,
RS232 interface, Ethernet interface.
6. novel sleep therapeutic equipment electrocardio processing system as described in claim 1, it is characterised in that：The DAC digital-to-analogue conversions
Module is 12-bit digital-to-analog converter.
7. novel sleep therapeutic equipment electrocardio processing system as described in claim 1, it is characterised in that：The ADC analog-to-digital conversions
Module is 16 analog-digital converters or 24 analog-digital converters.
8. novel sleep therapeutic equipment electrocardio processing system as claimed in claim 4, it is characterised in that：The amplifier AMP2 is
AD623A amplifiers.
9. novel sleep therapeutic equipment electrocardio processing system as claimed in claim 2, it is characterised in that：Operational amplifier A MP7C,
Operational amplifier A MP8A is TL064 low-power consumption JFET input operational amplifiers.
10. novel sleep therapeutic equipment electrocardio processing system as claimed in claim 3, it is characterised in that：Operational amplifier A MP7D
For TL064 low-power consumption JFET input operational amplifiers.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201820063839.3U CN208065578U (en) | 2018-01-16 | 2018-01-16 | A kind of novel sleep therapeutic equipment electrocardio processing system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201820063839.3U CN208065578U (en) | 2018-01-16 | 2018-01-16 | A kind of novel sleep therapeutic equipment electrocardio processing system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN208065578U true CN208065578U (en) | 2018-11-09 |
Family
ID=64035111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201820063839.3U Withdrawn - After Issue CN208065578U (en) | 2018-01-16 | 2018-01-16 | A kind of novel sleep therapeutic equipment electrocardio processing system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN208065578U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107961440A (en) * | 2018-01-16 | 2018-04-27 | 苏州小蓝医疗科技有限公司 | A kind of new sleep therapeutic equipment electrocardio processing system |
-
2018
- 2018-01-16 CN CN201820063839.3U patent/CN208065578U/en not_active Withdrawn - After Issue
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107961440A (en) * | 2018-01-16 | 2018-04-27 | 苏州小蓝医疗科技有限公司 | A kind of new sleep therapeutic equipment electrocardio processing system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Field et al. | Moderate versus light pressure massage therapy leads to greater weight gain in preterm infants | |
| CN102526875B (en) | Digital insomnia therapeutic apparatus and treatment method | |
| CN105920735A (en) | Physical and psychological recovery feedback training device | |
| CN106075727A (en) | A kind of online diagnosis and therapy system based on nervus auricularis vagi stimulation instrument | |
| CN111544882A (en) | Novel cerebral stroke lower limb active rehabilitation system based on brain-computer interface and application | |
| CN202538166U (en) | Digital insomnia therapeutic apparatus | |
| CN103169466B (en) | Algesia monitoring system and monitoring method for anesthesia | |
| CN105125186B (en) | A kind of method and system of definite therapeutic intervention mode | |
| CN102698365B (en) | Intelligent acupuncture and moxibustion diagnosis and treatment instrument for treating migraine | |
| CN208065578U (en) | A kind of novel sleep therapeutic equipment electrocardio processing system | |
| CN107583196A (en) | A kind of electro photoluminescence closed-loop system based on EMG biofeedback | |
| CN205307611U (en) | Painful treatment device | |
| CN206081334U (en) | System of diagnosing on line based on ear vagus stimulation instrument | |
| CN107961440A (en) | A kind of new sleep therapeutic equipment electrocardio processing system | |
| CN201529321U (en) | Insomnia therapeutic apparatus | |
| CN208641548U (en) | Biofeedback type headache therapeutic equipment | |
| CN202198971U (en) | Device for recovering nerve functions | |
| CN108543217A (en) | A kind of apparatus for curing insomnia and Insomnia therapy method | |
| CN205494675U (en) | A device for treatment of insomnia disease | |
| CN210873619U (en) | Insomnia therapeutic instrument based on brain wave feedback | |
| CN205494676U (en) | Wear -type electro photoluminescence device | |
| CN105311743A (en) | Device for treating insomnia | |
| CN205612867U (en) | A treatment device and system for treatment of insomnia disease based on mobile terminal | |
| CN216257136U (en) | Electrocardiosignal controller of rehabilitation treatment bed | |
| CN219804150U (en) | Trigeminal nerve stimulation system for animal experiments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP02 | Change in the address of a patent holder |
Address after: 215000 West 5th Floor, Building 1, No. 233 Yunchuang Road, Jiangling Street, Wujiang District, Suzhou City, Jiangsu Province Patentee after: SUZHOU XIAOLAN MEDICAL TECHNOLOGY CO.,LTD. Address before: 215000 south side of Lianyang road and west side of Longqiao Road, Wujiang Economic and Technological Development Zone, Suzhou City, Jiangsu Province Patentee before: SUZHOU XIAOLAN MEDICAL TECHNOLOGY CO.,LTD. |
|
| CP02 | Change in the address of a patent holder | ||
| AV01 | Patent right actively abandoned |
Granted publication date: 20181109 Effective date of abandoning: 20240326 |
|
| AV01 | Patent right actively abandoned |
Granted publication date: 20181109 Effective date of abandoning: 20240326 |
|
| AV01 | Patent right actively abandoned | ||
| AV01 | Patent right actively abandoned |